Sponsor

Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques appears in 18 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials18
Recruiting shown3
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

18 shown
High-Intensity Interval Training in Low Versus Normal Oxygen: Effects on Body Fat and Gut Health in Adults Aged 50-75 With Overweight or Obesity (HYPOXFAT)NCT07796971 · lead sponsor · 2026-08-26
RECRUITING
Acute Effects of Isoenergetic HIIE vs. MICE on Key Parameters of Fat Mass Loss in Young Females With Overweight or ObesityNCT06868862 · lead sponsor · 2025-02-01
RECRUITING
Metabolic and Nutritional Responses to Acute High-intensity Interval Exercise Performed Under Hypoxic vs. Normoxic Conditions at Matched External Workload in Adults With Overweight and Obesity.NCT07814599 · lead sponsor · 2024-11-01
COMPLETED
Biking vs. Running: Comparison of EPOC, Substrate Oxidation, Appetite and Energy Intakes in Men With Overweight/Obesity.NCT06082310 · lead sponsor · 2023-01-11
COMPLETED
High-Intensity Interval Training and Fat Mass LossesNCT05311800 · lead sponsor · 2021-09-01
COMPLETED
Post Exercise Substrate Oxidation, Appetite and Energy Intakes in Overweight/Obese Postmenopausal Women (EScAPE)NCT04364061 · lead sponsor · 2019-11-01
COMPLETED
Health and Exercise Response in Children With Chronic and Auto-immune PathologiesNCT03913962 · collaborator · 2019-05-02
RECRUITING
Physical Activity and Cardiometabolic Health in Women With or Without Polycystic Ovary Syndrome (SCOPAP)NCT07659392 · collaborator · 2026-07-01
NOT_YET_RECRUITING
Appetite Response to Exercise- Versus Energy Restriction-induced Energy Deficit in Adolescents With Obesity.NCT04739189 · collaborator · 2021-08-28
COMPLETED
Appetite Response to Exercise- Versus Mixed (Exercise + Dietary Restriction)-Induced Energy Deficit in Adolescents With ObesityNCT04734639 · collaborator · 2021-04-24
COMPLETED
Validation of a French-version of the Leeds Food Preference Questionnaire in Normal Weight and Patients With ObesityNCT04041830 · collaborator · 2019-12-08
TERMINATED
Neuromuscular Plasticity in Response to Obesity: Effects of Mechanical Overload, Metabolic Disorders and AgeNCT04106570 · collaborator · 2019-12-02
TERMINATED
Effect of the Exercise-meal Timing on Energy Intake and Appetite in Adolescents With ObesityNCT03967782 · collaborator · 2019-08-31
COMPLETED
Effect of Exercise Timing on Energy Intake and Appetite in Adolescents With Obesity: the TIMEX 3 StudyNCT03968458 · collaborator · 2019-08-31
COMPLETED
Energy Intake and Exercise TimingNCT03807609 · collaborator · 2019-01-19
COMPLETED
Energy Intake and Energy Deficit in Obese AdolescentsNCT03466359 · collaborator · 2018-01-08
UNKNOWN
Evaluation of a Personalized Physical Activity Coaching Program in Parkinson's DiseaseNCT02816619 · collaborator · 2016-03-01
UNKNOWN
ADIposity and Bone Metabolism: Effects of eXercise-induced Weight Loss in Obese AdolescentsNCT02626273 · collaborator · 2015-09-01
UNKNOWN

Drugs studied in this sponsor's trials

0 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

No mapped drug interventions are published for this sponsor's trials. This does not mean the studies contain no drug interventions: some registry names have not been mapped to RxNorm.

Sponsor roles

collaborator12
lead sponsor6
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.